Healthcare - Biotechnology - NASDAQ - US
$ 1.99
-4.78 %
$ 180 M
Market Cap
-1.2
P/E
BALANCE SHEET
432 M
ASSETS
63.8 M
LIABILITIES
368 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Caribou Biosciences, Inc.
| Current Assets | 339 M |
| Cash & Short-Term Investments | 329 M |
| Receivables | 3.86 M |
| Other Current Assets | 6.16 M |
| Non-Current Assets | 93.4 M |
| Long-Term Investments | 51.3 M |
| PP&E | 40.5 M |
| Other Non-Current Assets | 1.59 M |
| Current Liabilities | 28.3 M |
| Accounts Payable | 3.12 M |
| Short-Term Debt | 1.2 M |
| Other Current Liabilities | 24 M |
| Non-Current Liabilities | 35.5 M |
| Long-Term Debt | 25.9 M |
| Other Non-Current Liabilities | 9.6 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 51.2 | 58.3 | 240.4 | 16.0 | 41.1 |
| Short Term Investments | 277.7 | 189.3 | 135.4 | 0 | 8.4 |
| Receivables | 3.9 | 4.7 | 8.1 | 5.2 | 4.0 |
| Inventory | 0 | (62.6) | (31.1) | 2.4 | 3.2 |
| Other Current Assets | 6.2 | 7.9 | 7.2 | 3.2 | 3.6 |
| Total Current Assets | 338.8 | 260.2 | 391.2 | 24.3 | 57.0 |
| PP&E | 40.5 | 34.9 | 4.9 | 3.5 | 4.3 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 51.3 | 77.1 | 45.3 | 7.6 | 0 |
| Other Long Term Assets | 1.6 | 1.5 | 1.0 | 0.6 | 0.6 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 432.2 | 373.8 | 442.4 | 36.0 | 61.9 |
| LIABILITIES | |||||
| Accounts Payable | 3.1 | 1.1 | 4.0 | 2.6 | 2.5 |
| Short Term Debt | 1.2 | 1.9 | 0 | 0.7 | 0.5 |
| Other Current Liabilities | 21.1 | 15.1 | 13.1 | 9.0 | 6.3 |
| Total Current Liabilities | 28.3 | 28.1 | 25.8 | 12.4 | 10.1 |
| Long Term Debt | 25.9 | 26.8 | 0 | 0.9 | 0 |
| Deferred Tax Income | 0.6 | 0.4 | 0.5 | 0.2 | 0.7 |
| Other Liabilities | 2.9 | 1.7 | 6.2 | 45.1 | 42.8 |
| Total Liabilities | 63.8 | 72.9 | 54.5 | 59.5 | 54.5 |
| EQUITY | |||||
| Common Stock | 8 K | 6 K | 6 K | 1 K | 1 K |
| Retained Earnings | (299.3) | (197.2) | (97.8) | (30.9) | 3.4 |
| Other Accumulative Comprehensive Income/Loss | 30 K | (1.5) | (0.1) | 0 | 0 |
| Total Equity | 368.4 | 300.9 | 387.8 | (23.4) | 7.5 |
| Total Liabilities and Equity | 432.2 | 373.8 | 442.4 | 36.0 | 61.9 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 73.8 | 60.8 | 60.3 | 60.0 | 60.0 |